Drug intelligence / Profile preview

CC2107

Development stage: Preclinical
Lead developer: CirCode Bio
Modality: RNA Therapeutics → Nucleic Acid Therapeutics

Overview

CC2107 is a preclinical-stage circular RNA (circRNA) therapeutic candidate being developed by CirCode Bio. Utilizing CirCode's proprietary circRNA platform, CC2107 is engineered to provide sustained expression of a therapeutic protein within host cells. Unlike traditional linear mRNA, circular RNA lacks free ends, which confers significant resistance to exonuclease-mediated degradation. This structural stability potentially offers a longer half-life and more durable protein production compared to linear mRNA therapies. While the specific therapeutic protein and target indication for CC2107 have not been publicly disclosed in detail, CirCode Bio's broader pipeline focuses on high-impact areas such as metabolic diseases, oncology, and protein replacement therapies.

Other names: CC2107-CirCode Bio-circular RNA therapeutic proteinCC-2107-CirCode Bio-circular RNA therapeutic proteinCC 2107-CirCode Bio-circular RNA therapeutic protein

Beyond the preview

Go deeper on CC2107.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CC2107.

Explore the full profile